[Dyspepsia: a more complex approach].
| Autor: | Mbadu Mbuzi E; Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14., Weber IP; Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14., Humair JP; Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14., Gillabert C; Centre médical de Lancy, Route de Chancy 59C, 1213 Petit-Lancy., Bastid C; Service de gastroentérologie et hépatologie, Hôpitaux universitaires de Genève, 1211 Genève 14. |
|---|---|
| Jazyk: | francouzština |
| Zdroj: | Revue medicale suisse [Rev Med Suisse] 2022 Sep 28; Vol. 18 (797), pp. 1784-1787. |
| DOI: | 10.53738/REVMED.2022.18.797.1784 |
| Abstrakt: | Dyspepsia is defined as epigastric pain that lasts at least one month and may be associated with a range of other upper gastrointestinal symptoms. Approximately 2/3 of outpatients with dyspepsia have a functional dyspepsia. The clinical assessment of dyspepsia is based on age of patients as well and the search for severity criteria. The endoscopy in cases of new-onset dyspepsia is recommended from an age of 55-60 and the presence of at least 1 severity criteria. A non-invasive test for Helicobacter pylori (HP) should be performed in all patients and followed by HP eradication when HP test is positive. The first-choice treatment of functional dyspepsia is a proton pump inhibitor (PPI) at maximal dose for 8 weeks. A therapeutic trial with a prokinetic or a central neuromodulator are alternatives to consider in case of failure of PPI treatment. Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|